Cargando…
Response to ‘Eruptive keratoacanthomas associated with dupilumab therapy’
Case of a patient developing multiple rashes of squamous cell carcinoma 6 weeks after the introduction of dupilumab due to atopic eczema.[Image: see text]
Autores principales: | Patchinsky, Alexandra, Kalita, Victoria, Muller, Philippe, Petitpain, Nadine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233080/ https://www.ncbi.nlm.nih.gov/pubmed/37275419 http://dx.doi.org/10.1002/ski2.197 |
Ejemplares similares
-
Transient eruptive keratoacanthomas associated with nivolumab
por: Antonov, Nina K., et al.
Publicado: (2019) -
“Nevoid Eruptive Keratoacanthoma” - Yet Another Atypical Manifestation of Generalized Keratoacanthoma
por: Sen, Sumit, et al.
Publicado: (2016) -
Eruptive Keratoacanthomas in a Red Tattoo
por: Linares-Gonzalez, Laura, et al.
Publicado: (2020) -
Use of photodynamic therapy and acitretin in generalized eruptive keratoacanthoma of Grzybowski
por: Mlacker, Stephanie, et al.
Publicado: (2017) -
A Case of Keratoacanthoma Associated with Basal Cell Carcinoma
por: Kim, Tae Hyung, et al.
Publicado: (2015)